Advertisement

America's Healthcare System Ranked Last Among High-Income Nations β€” Again

The Commonwealth Fund's annual international healthcare comparison has once again placed the US last among 10 high-income nations on overall health system performance, despite spending $4.5 trillion annually β€” more than any other country on Earth.

America's Healthcare System Ranked Last Among High-Income Nations β€” Again

The Commonwealth Fund's annual Mirror on the Wall report has ranked the United States last among 10 high-income nations in overall healthcare system performance for the seventh consecutive year. The ranking covers five dimensions: access to care, care process quality, administrative efficiency, equity, and health outcomes. The US ranks last or near-last in all five categories despite spending $4.5 trillion on healthcare annually β€” more per capita than any other high-income nation by a factor of two.

The contrast with peer nations is stark and specific. Americans pay $11,000 per person per year for healthcare, compared to $6,200 in Germany (the second most expensive), $5,400 in France, and $4,300 in the UK. Yet American life expectancy of 76.4 years is the lowest of the 10 countries, and infant mortality is the highest. Preventable and treatable death rates in the US are double the best-performing nations.

The reasons are structural. Unlike every other high-income nation, the US lacks universal coverage β€” 26 million Americans remain uninsured. Administrative costs consume 34% of US healthcare spending, compared to 12% in Canada and 8% in Germany. Drug prices are 2-4x higher in the US than in peer nations due to the absence of government price negotiation. And the fragmented delivery system creates coordination failures that harm patients and waste resources.

The top-ranked nation, Australia, spends half what the US does and delivers better outcomes on every measured dimension. The evidence that the US could dramatically improve its health system performance while spending less is substantial β€” the political will to act on that evidence remains elusive.

← The US vs. The International Criminal Court: America's Compl… Novo Nordisk vs. Eli Lilly: The Battle to Dominate America's… β†’
Free Newsletter

Stay Ahead of Every Story

Breaking news, daily digests, and expert analysis delivered to your inbox β€” covering AI, Tech, Business, Finance, World, and Health.

Breaking alerts Daily digest Unsubscribe anytime

By subscribing you agree to our Privacy Policy. No spam, ever. Unsubscribe anytime.

πŸ”’ CAN-SPAM Compliant βœ“ No Credit Card βœ“ Free Forever